Fajri Gafar

About Fajri Gafar

Fajri Gafar, With an exceptional h-index of 7 and a recent h-index of 7 (since 2020), a distinguished researcher at Rijksuniversiteit Groningen, specializes in the field of Infectious diseases, tuberculosis, pharmacotherapy, clinical pharmacology, pharmacoepidemiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin-or multidrug-resistant tuberculosis in Indonesia

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis

Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?

TB therapeutic drug monitoring–analysis of opportunities in Romania and Ukraine

Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis

Treatment outcomes of childhood tuberculous meningitis in a real-world retrospective cohort, Bandung, Indonesia

Optimizing antimicrobial and host-directed therapies to improve clinical outcomes of childhood tuberculous meningitis

Optimization of tuberculosis treatment in children and adolescents

Fajri Gafar Information

University

Position

PhD Candidate

Citations(all)

158

Citations(since 2020)

158

Cited By

23

hIndex(all)

7

hIndex(since 2020)

7

i10Index(all)

6

i10Index(since 2020)

6

Email

University Profile Page

Google Scholar

Fajri Gafar Skills & Research Interests

Infectious diseases

tuberculosis

pharmacotherapy

clinical pharmacology

pharmacoepidemiology

Top articles of Fajri Gafar

Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin-or multidrug-resistant tuberculosis in Indonesia

European Journal of Drug Metabolism and Pharmacokinetics

2021/5

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis

2023/3/1

Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?

The International Journal of Tuberculosis and Lung Disease

2023/5/1

TB therapeutic drug monitoring–analysis of opportunities in Romania and Ukraine

The International Journal of Tuberculosis and Lung Disease

2023/11/1

Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis

Archives of disease in childhood

2022/1/1

Treatment outcomes of childhood tuberculous meningitis in a real-world retrospective cohort, Bandung, Indonesia

Emerging Infectious Diseases

2022/3

Optimizing antimicrobial and host-directed therapies to improve clinical outcomes of childhood tuberculous meningitis

Clinical Infectious Diseases

2022/7/15

Fajri Gafar
Fajri Gafar

H-Index: 3

Optimization of tuberculosis treatment in children and adolescents

2022

Fajri Gafar
Fajri Gafar

H-Index: 3

Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review

2020/8/1

Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data

European Respiratory Journal

2020/10/1

Fajri Gafar
Fajri Gafar

H-Index: 3

Taichi Ochi
Taichi Ochi

H-Index: 2

Emigrants and Immigrants

2020

See List of Professors in Fajri Gafar University(Rijksuniversiteit Groningen)

Co-Authors

academic-engine